nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
BACH1调控Nrf2/HO-1轴在糖尿病肾病铁死亡和氧化应激的作用
基金项目(Foundation): 湖南省自然科学基金项目(2025JJ81088)
邮箱(Email): dxy2167@163.com
DOI: 10.13423/j.cnki.cjcmi.010183
发布时间: 2026-07-23
出版时间: 2026-07-23
网络发布时间: 2026-07-23
移动端阅读
摘要:

目的 探讨BTB域和CNC同系物1(BACH1)在糖尿病肾病(DN)发生发展中的作用及其通过核因子E2相关因子2/血红素加氧酶-1(Nrf2/HO-1)信号通路影响铁死亡的分子机制。方法 8周龄db/db小鼠随机分为模型组、BACH1-shRNA敲低组及阴性对照组,并以db/m小鼠作为正常对照。通过肾脏原位注射慢病毒敲低肾组织BACH1表达,检测小鼠肾功能指标血肌酐(Scr)、尿素氮(BUN)、尿微量白蛋白/肌酐比值(UACR);通过苏木精-伊红(HE)、过碘酸-雪夫(PAS)和Masson染色观察肾脏病理变化;试剂盒检测氧化应激指标超氧化物歧化酶(SOD)、丙二醛(MDA)、还原型谷胱甘肽/氧化型谷胱甘肽(GSH/GSSG)、活性氧(ROS)及铁死亡相关指标亚铁离子含量、脂质过氧化物(LPO);利用Westernblot法和实时荧光定量PCR技术检测BACH1、核Nrf2、HO-1、谷胱甘肽过氧化物酶4(GPX4)、溶质载体家族7成员11(SLC7A11)的表达。结果 与db/m组相比,db/db组小鼠肾组织中BACH1的mRNA和蛋白表达均显著上调,并伴随Scr、BUN和UACR显著升高,肾脏出现明显的病理学改变;同时SOD活性显著降低,MDA含量显著升高,GSH/GSSG比值显著下降,ROS水平显著升高;组织亚铁离子含量和LPO水平显著升高,GPX4和SLC7A11表达显著下调,Nrf2核转位水平下降。而敲低BACH1后,db/db小鼠Scr、BUN和UACR均显著降低,肾脏病理损伤明显减轻;同时SOD活性升高,MDA含量降低,GSH/GSSG比值回升,ROS水平降低;铁死亡进程受到抑制,组织铁含量和LPO水平显著降低,GPX4和SLC7A11表达显著上调。同时,敲低BACH1显著促进了Nrf2核转位,并上调了其下游靶蛋白HO-1的表达。结论BACH1在DN中高表达,其可能通过抑制Nrf2/HO-1通路,加剧氧化应激与铁死亡,从而促进DN的进展。敲低BACH1可激活Nrf2/HO-1通路,发挥肾脏保护作用,为DN治疗提供了新的靶点。

Abstract:

Objective To investigate the role of BTB domain and CNC homolog 1 (BACH1) in the development of diabetic nephropathy (DN) and its molecular mechanism by which it mediates ferroptosis through the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) signaling pathway. Methods Eight-week-old db/db mice were randomly divided into model, BACH1-shRNA knockdown, and negative control groups, with db/m mice serving as normal controls. BACH1 expression in renal tissue was knocked down by intraparenchymal injection of lentivirus. Renal function parameters, including serum creatinine (Scr), blood urea nitrogen (BUN), and urine albumin-to-creatinine ratio (UACR), were measured. Renal pathological changes were observed via hematoxylin-eosin (HE), periodic acid-Schiff (PAS), and Masson staining. Oxidative stress indicators, including superoxide dismutase (SOD), malondialdehyde (MDA), reduced glutathione/oxidized glutathione (GSH/GSSG), and reactive oxygen species (ROS), as well as ferroptosis-related indicators, including ferrous ion content and lipid peroxide (LPO), were detected using commercial kits. The expression levels of BACH1, nuclear Nrf2, HO-1, glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11) were detected by Western blot and real-time quantitative fluorescent PCR. Results Compared with the db/m group, the db/db group showed upregulated BACH1 mRNA and protein expression in renal tissues. This was accompanied by significant increases in Scr, BUN, and UACR, along with marked renal pathological changes. In addition, SOD activity was significantly decreased, MDA content was increased, the GSH/GSSG ratio was reduced, and ROS levels were elevated. Tissue iron content and LPO levels were significantly increased, while GPX4 and SLC7A11 expression were downregulated, and Nrf2 nuclear translocation was reduced. After BACH1 knockdown, Scr, BUN, and UACR were significantly reduced, and renal pathological injury was markedly alleviated. SOD activity increased, MDA content decreased, GSH/GSSG ratio recovered, and ROS levels decreased. Ferroptosis was inhibited, as evidenced by significantly reduced tissue iron content and LPO levels, along with significantly upregulated GPX4 and SLC7A11 expression. Furthermore, BACH1 knockdown significantly promoted Nrf2 nuclear translocation and upregulated the expression of its downstream target protein HO-1. Conclusion BACH1 is highly expressed in DN and may promote the progression of DN by inhibiting the Nrf2/HO-1 pathway, thereby exacerbating oxidative stress and ferroptosis. Knockdown of BACH1 activates the Nrf2/HO-1 pathway, exerting a renal protective effect, and provides a new potential therapeutic target for DN.

参考文献

[1] Watanabe K, Sato E, Mishima E, et al. What's new in the molecular mechanisms of diabetic kidney disease: Recent advances[J]. Int J Mol Sci, 2022, 24(1):570.

[2] 李书楠, 张诗妍, 邓亚楠, 等. 1990-2021年中国2型糖尿病肾病的疾病负担变化趋势及预测研究[J]. 中国全科医学, 2025, 28 (33): 4214-4226.

[3] Jin Q, Liu T, Qiao Y, et al. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols[J]. Front Immunol, 2023, 14:1185317.

[4] Wheeler D C, Stefánsson B V, Jongs N, et al. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial[J]. Lancet Diabetes Endocrinol, 2021, 9(1):22-31.

[5] Yu H, Fu L, Zhang C, et al. Targeting ferroptosis with natural products to treat diabetes and its complications: opportunities and challenges[J]. Phytother Res, 2025, 39(12):5695-5716.

[6] Wang H, Liu D, Zheng B, et al. Emerging role of ferroptosis in diabetic kidney disease: Molecular mechanisms and therapeutic opportunities[J]. Int J Biol Sci, 2023, 19(9):2678-2694.

[7] Li J, Li L, Zhang Z, et al. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy[J]. Front Immunol, 2023, 14:1294317.

[8] Tang L ,Yang C ,Peng Y , et al.YAP/Nrf2 suppresses ferroptosis to alleviate acute lung injury induced by intestinal ischemia/reperfusion.[J].Redox Biol,2025,86:103811.

[9] Liu X ,Chen C ,Zhu S , et al.ACSF2-PGK1 interaction promotes ferroptosis in renal tubular epithelial cells of diabetic nephropathy by regulating Keap1/Nrf2 signaling.[J].Redox Rep,2025,30(1):2529618.

[10] Li S ,Xiao H ,Zhang X , et al.Reynoutrin activates Sirt1/Foxo3a and Nrf2 pathway via targeting Fyn to ameliorate diabetic nephropathy.[J].Phytomedicine,2025,146:157158.

[11] Nishizawa H, Yamanaka M, Igarashi K. Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal[J]. FEBS J, 2023, 290(7):1688-1704.

[12] Eun M, Kim D, Shin S I, et al. Chromatin accessibility analysis and architectural profiling of human kidneys reveal key cell types and a regulator of diabetic kidney disease[J]. Kidney Int, 2024, 105(1):150-164.

[13] Li X, Lu L, Hou W, et al. The SETD8/ELK1/bach1 complex regulates hyperglycaemia-mediated EndMT in diabetic nephropathy[J]. J Transl Med, 2022, 20(1):147.

[14] Yuan Z, Li J, Xiao F, et al. Sinensetin protects against periodontitis through binding to Bach1 enhancing its ubiquitination degradation and improving oxidative stress[J]. Int J Oral Sci, 2024, 16(1):38.

[15] Hu Y, Li J, Hu L, et al. BACH1 impairs hepatocyte regeneration after hepatectomy with repeated ischemia/reperfusion by reprogramming energy metabolism and exacerbating oxidative stress[J]. Biochem Pharmacol, 2024, 226:116377.

[16] 苏珊珊,郭兆安,杨欢,等.芪蛭降糖胶囊调控NLRP3/caspase-1/GSDMD通路抑制足细胞焦亡改善糖尿病肾损伤的机制研究[J].细胞与分子免疫学杂志,2025,41(3):204-210.

[17] Wang Y, Wang W, Su L, et al. BACH1 changes microglial metabolism and affects astrogenesis during mouse brain development[J]. Dev Cell, 2024, 59(1):108-124.e7.

[18] 王雪松,康弟,王莹莹,等.铁死亡:从分子到疾病[J].细胞与分子免疫学杂志,2025,41(10):937-953.

[19] Zhang Y, Zhang X, Ren J, et al. Methylglyoxal induces oxidative stress and ferroptosis of renal tubular epithelial cells in acute and chronic kidney injury mice[J]. Front Cell Dev Biol, 2025, 13:1604575.

[20] Xie X, Tian L, Zhao Y, et al. BACH1-induced ferroptosis drives lymphatic metastasis by repressing the biosynthesis of monounsaturated fatty acids[J]. Cell Death Dis, 2023, 14(1):48.

[21] Wang Y, Qiu J, Yan H, et al. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice[J]. Arch Toxicol, 2024, 98(6):1781-1794.

[22] Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation[J]. Autophagy, 2020, 17(9):2054-2081.

[23] Wang H, Yu X, Liu D, et al. VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2/HO-1 signaling pathway in diabetic nephropathy[J]. Adv Sci (Weinh), 2023, 11(10):e2305563.

[24] [24 Nan W, Zhou W M, Zi J L, et al. Ferroptosis and bone metabolic diseases: the dual regulatory role of the Nrf2/HO-1 signaling axis[J]. Front Cell Dev Biol, 2025, 13:1615197.

[25] Lignitto L, LeBoeuf S E, Homer H, et al. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of bach1[J]. Cell, 2019, 178(2):316-329.e18.

[26] Wu D ,Zhang K ,Tan J , et al.Nrf2/Bach1 axis regulates redox homeostasis and energy metabolism to optimize Sertoli cell-mediated efferocytosis.[J].Mol Cell Endocrinol,2025,610:112661.

[27] Namgaladze D, Fuhrmann DC, Brüne B. Interplay of Nrf2 and BACH1 in inducing ferroportin expression and enhancing resistance of human macrophages towards ferroptosis[J]. Cell Death Discov, 2022, 8(1):327.

[28] Cui C ,Feng L ,Su L , et al.METTL14 promotes ischemic stroke pathogenesis by mediating m6A methylation modification of BACH1 to enhance OGD/R-induced neuronal damage and facilitate ferroptosis in SK-N-SH cells.[J].Neuroscience,2026,600:187-195.

基本信息:

DOI:10.13423/j.cnki.cjcmi.010183

中图分类号:R587.2;R692.9

引用信息:

[1]龙圣海,王脉桃,唐齐林,等.BACH1调控Nrf2/HO-1轴在糖尿病肾病铁死亡和氧化应激的作用[J].细胞与分子免疫学杂志().DOI:10.13423/j.cnki.cjcmi.010183.

基金信息:

湖南省自然科学基金项目(2025JJ81088)

发布时间:

2026-07-23

出版时间:

2026-07-23

网络发布时间:

2026-07-23

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文